rs2294008, PSCA;JRK

N. diseases: 28
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE Although modest limitations and potential bias cannot be eliminated, this meta-analysis suggests that PSCA -rs2294008C>T and -rs2976392G>A are potential factors of GC development for Eastern Asians, and future work may incorporate these findings and evaluate these variants as potential markers for screening and early diagnosis of GC. 22155405 2012
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE Association of the PSCA rs2294008 C>T polymorphism with gastric cancer risk: evidence from a meta-analysis. 22938475 2012
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE From these results we conclude that the PSCA rs2294008 polymorphism is involved in the susceptibility to GC and DU, as well as in the prognosis of the diffuse-type of GC in Caucasians. 25721731 2015
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation GWASCAT Genome-wide association study identifies gastric cancer susceptibility loci at 12q24.11-12 and 20q11.21. 30281874 2018
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE However, subtype-specific associations were observed for gastric cardia adenocarcinomas at MUC1/TRIM46/1q22 rs2070803 [HRAA versus GA+GG = 2.16; 95% confidence interval (CI) = 1.24-3.78; P = 0.0068] and LTA/TNF/6p21.33 rs1799724 (HRTT+CT versus CC = 1.30; 95% CI = 1.07-1.57; P = 0.0077), and for diffuse-type GC at PSCA/8q24.3 rs2294008 (HRTT versus CT+CC = 1.99; 95% CI = 1.33-2.97; P = 7.8E-04). 29028942 2017
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation GWASCAT Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies. 26701879 2017
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE If validated in further studies, PSCA rs2294008</span> could be useful marker of sur</span>vival assessment and individualized clinical therapy for gastric cancer, particularly among the diffuse-type gastric cancer. 21064099 2011
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE In addition, our data indicate that rs22</span>94008 of PSCA is involved in GC susceptibility and confer its effect primarily in noncardia tumors (OR = 1.30, 95% CI 1.12-1.53, P < 10(-4)). 24146278 2014
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE In conclusion, the results indicated that the PSCA rs2294008 T and rs2976392 A alleles were low-penetrate risk factors for GCa in this study population. 26848528 2016
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE In conclusion, The T allele of PSCA rs2294008 is associated with increased risk of gastric cancer, especially intestinal type, poorly differentiated, early onset, and noncardia gastric cancer in Chinese population. 21268123 2011
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation GWASCAT Loss-of-function variants in ATM confer risk of gastric cancer. 26098866 2015
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE Many epidemiological studies have identified the PSCA rs2294008 T-allele as a risk factor of GC, while others have found an association between the rs2294008 C-allele and risk of DU and gastric ulcer (GU). 31839644 2019
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE Our study showed that rs2294008 in the PSCA gene was associated with increased risks of gastric cancer in a Korean population, suggests that rs2294008 might play an important role in gastric carcinogenesis. 21538581 2011
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE Our study suggested rs2294008 in the PSCA gene to be associated with increased risk of gastric cancer and rs2070803 in MUC1 to play a protective role in a Chinese population. 22938426 2012
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE Polymorphisms of PSCA (rs2976392, rs2294008) and MUC1 (rs4072037) genes are associated with GC and HRAG. 25503145 2014
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE Previous genomewide association studies identified prostate stem cell antigen (PSCA) as a gastric cancer (GC) susceptibility gene and showed an association between GC and the T allele of the single nucleotide polymorphism rs2294008 (C/T) in this gene. 25727947 2015
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE PSCA rs2294008/rs2976392 showed a significant, multiplicative interaction with H. pylori infection in risk of GC. 28220687 2017
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE Recently, three genome-wide association studies have identified the PSCA (prostate stem cell antigen) rs2294008 polymorphism (C > T) associated with susceptibility to gastric cancer, bladder cancer, and duodenal ulcers, highlighting its critical role in disease pathogenesis. 27001215 2016
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE Recently, two genome-wide association studies identified a significant association between the prostate stem cell antigen (PSCA) rs2294008 (C>T) polymorphism and risk of diffuse-type of gastric cancer in Asians and bladder cancer in Caucasians, respectively. 20083643 2010
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE Specifically, a significant increased stomach cancer risk was associated with PSCA rs2294008 (CT vs. CC: adjusted OR = 1.37, 95% CI = 1.07-1.74, and CT/TT vs.CC: adjusted OR = 1.30, 95% CI = 1.03-1.63), PSCA rs2976392 (AG vs. GG: adjusted OR = 1.30, 95% CI = 1.02-1.65, and AG/AA vs. GG: adjusted OR = 1.26, 95% CI = 1.00-1.59), or PLCE1 rs2274223 (AG vs. AA: adjusted OR = 1.48, 95% CI = 1.15-1.90, and AG/GG vs. AA: adjusted OR = 1.45, 95% CI = 1.14-1.84), respectively. 25658482 2015
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE The rs2294008 C/T polymorphism of the PSCA gene was significantly associated with the susceptibility to GC. 20230293 2010
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE The rs2294008 polymorphism in PSCA increases the risk of noncardia gastric cancer and its precursors in white individuals but protects against proximal cancers. 21070776 2011
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE The C allele of rs2294008 at PSCA was associated with increased risk of duodenal ulcer (odds ratio (OR) = 1.84; P = 3.92 × 10(-33)) in a recessive model but was associated with decreased risk of gastric cancer (OR = 0.79; P = 6.79 × 10(-12)), as reported previously. 22387998 2012
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE The PSCA rs2294008 C>T polymorphism may be acting through induction of gastric mucosal atrophy, finally leading to development of gastric ulcer and gastric cancer in PSCA rs2294008 T allele carriers, but not duodenal ulcer. 25582162 2015
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.800 GeneticVariation BEFREE The two loci of PSCA (rs2294008 and rs2976392) were both significantly associated with GC susceptibility and in linkage disequilibrium. 22426141 2012